Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
about
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapsesRegression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?Incidental demyelinating inflammatory lesions in asymptomatic patients: a Brazilian cohort with radiologically isolated syndrome and a critical review of current literature.A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesQuantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypesPhysical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatmentSystematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost?Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.Diagnostic biomarkers in multiple sclerosis.Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets.Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disabilityImmunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness.Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.Clinical-magnetic resonance imaging correlations in multiple sclerosis.Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.MRI in multiple sclerosis: what's inside the toolbox?Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential?Quantitative electroencephalography reveals different physiological profiles between benign and remitting-relapsing multiple sclerosis patientsMultiple sclerosis lesions: insights from imaging techniques.Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach.Interferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis.Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations.Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.Therapeutic strategies in multiple sclerosis. I. ImmunotherapyDrug treatment of multiple sclerosis. Clinical review was unsystematic.Neuroimaging in multiple sclerosis: neurotherapeutic implications.Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.Therapeutic developments in multiple sclerosis.Composite MRI scores improve correlation with EDSS in multiple sclerosisEffects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials.Aggressive multiple sclerosis: proposed definition and treatment algorithm.Magnetic resonance imaging in multiple sclerosis--patients' experiences, information interests and responses to an education programme.The emerging role of MRI in multiple sclerosis and the new diagnostic criteria.
P2860
Q24288978-1FE7FC6B-D3D2-4312-A8DB-7478FD0DAAA1Q26998513-4F992CD3-F8AF-43A5-9CB5-4FA33C0B8E28Q27690295-4EA6407B-AA7F-400E-A8BD-E24766061F6CQ28068709-50C91BB5-35B1-402E-9FA9-47025E29B4D0Q28299872-5C142614-0F27-498C-99FA-7E6E0236B483Q28301630-AAAC1CC8-5CEE-4976-82E6-0D11A6E518F1Q28363134-80A50D68-9CEB-4569-84FD-3F75D9026129Q30585635-FBC61B8A-B09C-4559-82B3-D302FBE7EDB3Q30598338-BC01E316-4997-4C28-A680-6C3F3E42BE39Q30640097-6D211726-843B-4C3F-8CB1-F95B29972A54Q30655532-40D552ED-FDA6-4F2B-AEF2-3318B26C3ED1Q30666435-AF819E9A-8D12-4B28-A084-34285B98C9F2Q30712257-B451536D-DCA7-4173-8F2E-5A716664AF89Q30816299-9E897774-9BF4-421B-88C4-AEDEB28B2110Q30869048-B54855F9-C4A8-4EA4-9762-C1A055C591CCQ30983016-6D426540-EC34-43F7-9F47-C0874CF8F52CQ30989935-691CFBDC-A5D9-4960-86BC-598F63451ADCQ30992091-CB43CEFD-9216-4249-957C-970A193FAA9AQ31027945-30C1734C-F423-4D2C-8B65-71E538776A92Q31037055-A99A28BB-83AA-4496-8741-6FC76B16A6F6Q31132442-CAA82953-AC9E-44D7-AC1D-D8926533F1D5Q33289264-273E7013-73A2-48AD-9CDF-ACBEF85FEA38Q33386254-2C244C5D-3C9F-479F-8B08-952B5DD9D32FQ33505423-551D8FB4-93A8-4438-93D8-C8BEAC55AC04Q33534161-135273BC-F678-4F4A-BD21-65D5BFE5B03FQ33579409-D022A5B7-FAA4-4386-A52C-DDE3585E98DBQ33634866-DE7AA47C-2683-45FB-8986-58181BE23B26Q33692568-76E52AEF-2F38-42E6-B3F1-01C900D33109Q33787783-47F3E196-C2F1-42E0-8E87-8319B4F052ADQ33798254-C9F17F0E-A0D6-4544-BF15-FAB81BF3C92DQ33803981-D1AE5995-332C-4DCF-A958-EF582D82DA48Q33806032-91E9AC71-36D9-4D30-BC38-62C5C6444F8CQ33807332-7505E8C8-A775-4EE1-8270-84285C9A10FAQ34074776-A60FFA0E-0456-4CE0-9D50-98C558E0D1FAQ34109873-51313FD1-3B4C-4A71-9B4E-6B60F9153045Q34136565-5F555E34-7F76-4C6A-8C76-BBB1EA012490Q34223767-4AB697FC-7E08-4EE7-9A2F-071ED135F550Q34478828-FB533E42-3DC2-4B9F-9AE3-6093079BEFE6Q34557520-A2F8F78D-5AF5-4539-BB06-4E7E966E061CQ34590306-D76372B1-57A1-4BE7-8332-FD9F8565383F
P2860
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Predictive value of gadolinium ...... inium MRI Meta-analysis Group.
@en
type
label
Predictive value of gadolinium ...... inium MRI Meta-analysis Group.
@en
prefLabel
Predictive value of gadolinium ...... inium MRI Meta-analysis Group.
@en
P2093
P50
P921
P1433
P1476
Predictive value of gadolinium ...... linium MRI Meta-analysis Group
@en
P2093
A Schoetzau
H L Weiner
K Schweikert
P304
P356
10.1016/S0140-6736(98)03053-0
P407
P577
1999-03-01T00:00:00Z